KSF News, Updates, & Insights

KSF Appointed as Lead Counsel in CytRx Securities Fraud Lawsuit for Secondary Offering

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., announce that on June 17, 2014, the United States District Court for the Central District of California appointed KSF as sole lead counsel in Chen v. CytRx Corporation, et al., 2:14-cv-01956-GHK, a securities fraud class action brought on behalf of all persons who purchased or otherwise acquired the publicly traded common stock of CytRx Corporation (Nasdaq: CYTR) between November 20, 2013 and March 13, 2014. KSF will be filing a consolidated complaint in the action shortly, and shareholders who purchased CytRx stock in the Secondary Offering on January 31, 2014 should contact KSF concerning their legal rights and how this case might affect you.

What You May Do

If you purchased shares of CytRx at $6.50 per share at any time between January 31 and February 5, 2014 and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, call toll-free at 1-877-515-1850, or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com) or KSF Partner Melinda Nicholson (melinda.nicholson@ksfcounsel.com).